These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21150591)

  • 61. Antiretroviral therapy in acute and recent HIV infection: a prospective multicenter stratified trial of intentionally interrupted treatment.
    Volberding P; Demeter L; Bosch RJ; Aga E; Pettinelli C; Hirsch M; Vogler M; Martinez A; Little S; Connick E;
    AIDS; 2009 Sep; 23(15):1987-95. PubMed ID: 19696651
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL.
    Gianotti N; Lorenzini P; Cozzi-Lepri A; De Luca A; Madeddu G; Sighinolfi L; Pinnetti C; Santoro C; Meraviglia P; Mussini C; Antinori A; d'Arminio Monforte A;
    J Antimicrob Chemother; 2019 Sep; 74(9):2732-2741. PubMed ID: 31173639
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Routine CD4 monitoring in HIV patients with viral suppression: Is it really necessary? A Portuguese cohort.
    Duro R; Rocha-Pereira N; Figueiredo C; Piñeiro C; Caldas C; Serrão R; Sarmento A
    J Microbiol Immunol Infect; 2018 Oct; 51(5):593-597. PubMed ID: 28712820
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Structured treatment interruptions (STI) in chronic suppressed HIV infection in adults.
    Pai NP; Tulsky JP; Lawrence J; Colford JM; Reingold AL
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005482. PubMed ID: 16235406
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Scale-up of Routine Viral Load Testing in Resource-Poor Settings: Current and Future Implementation Challenges.
    Roberts T; Cohn J; Bonner K; Hargreaves S
    Clin Infect Dis; 2016 Apr; 62(8):1043-8. PubMed ID: 26743094
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Triple-class HIV antiretroviral therapy failure in an Australian primary care setting.
    Bloch M; Farris M; Tilden D; Gowers A; Cunningham N
    Sex Health; 2010 Mar; 7(1):17-24. PubMed ID: 20152091
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Therapeutic drug monitoring of antiretrovirals for people with HIV.
    Kredo T; Van der Walt JS; Siegfried N; Cohen K
    Cochrane Database Syst Rev; 2009 Jul; (3):CD007268. PubMed ID: 19588422
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Differentiated HIV care in sub-Saharan Africa: a scoping review to inform antiretroviral therapy provision for stable HIV-infected individuals in Kenya.
    Hagey JM; Li X; Barr-Walker J; Penner J; Kadima J; Oyaro P; Cohen CR
    AIDS Care; 2018 Dec; 30(12):1477-1487. PubMed ID: 30037312
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Trends in CD4 cell count response to first-line antiretroviral treatment in HIV-positive patients from Asia, 2003-2013: TREAT Asia HIV Observational Database Low Intensity Transfer.
    De La Mata NL; Ly PS; Ng OT; Nguyen KV; Merati TP; Pham TT; Lee MP; Choi JY; Sohn AH; Law MG; Kumarasamy N
    Int J STD AIDS; 2017 Nov; 28(13):1282-1291. PubMed ID: 28632481
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Assessing the Efficacy of Second-Line Antiretroviral Treatment for HIV Patients Failing First-Line Antiretroviral Therapy in Iran: A Cohort Study.
    Rasooli-Nejad M; Khazaee-Pool M; Abbasian L; Bayat Jozani Z; Ahsani-Nasab S; Moradmand Badie B; Pargar A; Esmaeeli Djavid G
    Acta Med Iran; 2017 Apr; 55(4):233-240. PubMed ID: 28532134
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A model for reduced HIV-1 viral load monitoring in resource-limited settings.
    Bryant L; Smith N; Keiser P
    J Int Assoc Provid AIDS Care; 2013; 12(1):67-71. PubMed ID: 22553318
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Impaired CD4+ cell recovery during antiretroviral therapy in patients with HIV resistance mutations.
    Sühs KW; Stoll M; Diem R; Schmidt RE; Heiken H
    Arch Virol; 2012 Mar; 157(3):433-40. PubMed ID: 22179846
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Routine versus Targeted Viral Load Strategy among Patients Starting Antiretroviral in Hanoi, Vietnam.
    Pollack TM; Duong HT; Pham TT; Nguyen TD; Libman H; Ngo L; McMahon JH; Elliott JH; Do CD; Colby DJ
    J Int AIDS Soc; 2019 Mar; 22(3):e25258. PubMed ID: 30897303
    [TBL] [Abstract][Full Text] [Related]  

  • 74. HIV Viral Load Monitoring Among Patients Receiving Antiretroviral Therapy - Eight Sub-Saharan Africa Countries, 2013-2018.
    Lecher SL; Fonjungo P; Ellenberger D; Toure CA; Alemnji G; Bowen N; Basiye F; Beukes A; Carmona S; de Klerk M; Diallo K; Dziuban E; Kiyaga C; Mbah H; Mengistu J; Mots'oane T; Mwangi C; Mwangi JW; Mwasekaga M; N'tale J; Naluguza M; Ssewanyana I; Stevens W; Zungu I; Bhairavabhotla R; Chun H; Gaffga N; Jadczak S; Lloyd S; Nguyen S; Pati R; Sleeman K; Zeh C; Zhang G; Alexander H
    MMWR Morb Mortal Wkly Rep; 2021 May; 70(21):775-778. PubMed ID: 34043612
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pooled nucleic acid testing to identify antiretroviral treatment failure during HIV infection in Seoul, South Korea.
    Kim SB; Kim HW; Kim HS; Ann HW; Kim JK; Choi H; Kim MH; Song JE; Ahn JY; Ku NS; Oh DH; Kim YC; Jeong SJ; Han SH; Kim JM; Smith DM; Choi JY
    Scand J Infect Dis; 2014 Feb; 46(2):136-40. PubMed ID: 24228824
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinical Benefits and Cost-Effectiveness of Laboratory Monitoring Strategies to Guide Antiretroviral Treatment Switching in India.
    Freedberg KA; Kumarasamy N; Borre ED; Ross EL; Mayer KH; Losina E; Swaminathan S; Flanigan TP; Walensky RP
    AIDS Res Hum Retroviruses; 2018 Jun; 34(6):486-497. PubMed ID: 29620932
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Stable patients and patients with advanced disease: consensus definitions to support sustained scale up of antiretroviral therapy.
    Waldrop G; Doherty M; Vitoria M; Ford N
    Trop Med Int Health; 2016 Sep; 21(9):1124-30. PubMed ID: 27371814
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparative cost analysis of point-of-care versus laboratory-based testing to initiate and monitor HIV treatment in South Africa.
    Simeon K; Sharma M; Dorward J; Naidoo J; Dlamini N; Moodley P; Samsunder N; Barnabas RV; Garrett N; Drain PK
    PLoS One; 2019; 14(10):e0223669. PubMed ID: 31618220
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Differentiated Human Immunodeficiency Virus RNA Monitoring in Resource-Limited Settings: An Economic Analysis.
    Negoescu DM; Zhang Z; Bucher HC; Bendavid E;
    Clin Infect Dis; 2017 Jun; 64(12):1724-1730. PubMed ID: 28329208
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pooled nucleic acid testing to detect antiretroviral treatment failure in Mexico.
    Tilghman MW; Guerena DD; Licea A; Pérez-Santiago J; Richman DD; May S; Smith DM
    J Acquir Immune Defic Syndr; 2011 Mar; 56(3):e70-4. PubMed ID: 21124228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.